THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Head to Head Comparison of Upper Airway Stimulation and Continuous Positive Airway Pressure; a Pilot Study.

Recruiting

Conditions: Obstructive Sleep Apnea

First Posted Date: 2019-12-09

Last Posted Date: 2024-04-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 50

Registration Number: NCT04191512

Locations: 🇺🇸
Thomas Jefferson University Department of Otolaryngology, Philadelphia, Pennsylvania, United States

Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC

Early Phase 1

Active, not recruiting

Conditions: Recessive Dystrophic Epidermolysis Bullosa

Interventions: Drug: Rigosertib Sodium
Other: Quality-of-Life Assessment

First Posted Date: 2019-11-26

Last Posted Date: 2025-05-18

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 6

Registration Number: NCT04177498

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

POCUS Analysis of the Gastric Emptying Time of Orange Juice With and Without Pulp

Not Applicable

Completed

Conditions: Preoperative Period
Anesthesia

Interventions: Other: Point of care gastric ultrasound

First Posted Date: 2019-10-31

Last Posted Date: 2020-03-18

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 14

Registration Number: NCT04146233

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)

Not Applicable

Terminated

Conditions: Heart Failure
Sleep Disorder; Breathing-Related

Interventions: Behavioral: Active Patient Engagement

First Posted Date: 2019-10-21

Last Posted Date: 2021-05-27

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 2

Registration Number: NCT04133350

Locations: 🇩🇪
Herz- und Diabeteszentrum, Nordrhein-Westfalen, Bad Oeynhausen, Ruhr-Universität Bochum, Germany
🇩🇪
Ludgerus Clinic, Department of Cardiology, Clemens Hospital, Münster, Germany
🇺🇸
INOVA (Inova Heart and Vascular Institute, Inova Fairfax Hospital), Falls Church, Virginia, United States

and more 1 locations

Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor

Not Applicable

Completed

Conditions: Malignant Solid Neoplasm

Interventions: Other: Medical Chart Review
Other: Educational Intervention
Other: Survey Administration

First Posted Date: 2019-10-10

Last Posted Date: 2025-04-29

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 26

Registration Number: NCT04122118

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Behavioral: Acceptance and Commitment Therapy adapted for Cystic Fibrosis (ACT with CF)
Behavioral: Supportive Psychotherapy (Treatment as Usual Control)

First Posted Date: 2019-10-03

Last Posted Date: 2024-04-15

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 146

Registration Number: NCT04114227

Locations: 🇺🇸
Jefferson Center City Clinic for Behavioral Medicine, Philadelphia, Pennsylvania, United States

Enhanced Recovery After Surgery in Kidney Transplant Donors

Not Applicable

Recruiting

Conditions: Kidney Diseases
Opioid Use
Pain, Postoperative
Postoperative Nausea and Vomiting
Postoperative Complications

Interventions: Procedure: multimodal pain management
Other: goal directed fluid management
Other: preoperative carbohydrate loading
Procedure: Donor nephrectomy
Procedure: regional anesthesia

First Posted Date: 2019-10-01

Last Posted Date: 2023-04-18

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 42

Registration Number: NCT04110080

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Phase 2

Active, not recruiting

Conditions: Pancreatic Ductal Adenocarcinoma
Clinical Stage IIA Gastric Cancer AJCC v8
Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IIB Gastric Cancer AJCC v8
Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
Pathologic Stage III Gastric Cancer AJCC v8
Pathologic Stage IIIA Gastric Cancer AJCC v8
Pathologic Stage IIIC Gastric Cancer AJCC v8
Stage I Pancreatic Cancer AJCC v8

Interventions: Biological: Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE

First Posted Date: 2019-10-01

Last Posted Date: 2025-01-03

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 81

Registration Number: NCT04111172

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Exercise Prescription for the Improvement of Quality of Life in Elderly Patients With Multiple Myeloma

Not Applicable

Completed

Conditions: Plasma Cell Myeloma

Interventions: Other: Exercise Counseling
Behavioral: Exercise Intervention
Other: Questionnaire administration
Other: Quality-of-Life Assessment

First Posted Date: 2019-09-23

Last Posted Date: 2025-04-29

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 9

Registration Number: NCT04100044

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Anatomic Stage IIIB Breast Cancer AJCC v8
Estrogen Receptor Positive Tumor
Prognostic Stage IIIA Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Progesterone Receptor Positive Tumor
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IIIA Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8

Interventions: Other: Best Practice
Behavioral: Focus Group
Other: Text Message
Other: Questionnaire Administration

First Posted Date: 2019-09-12

Last Posted Date: 2024-06-10

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 332

Registration Number: NCT04086875

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸
Jefferson Health - Northeast (Aria Torresdale), Philadelphia, Pennsylvania, United States

and more 4 locations

Home Terms & Conditions Privacy Policy